Correction to: T cell leukemia control via Ras-Raf pathway inhibition with peptides • JML Journal of Medicine and Life

2018, Volume 11, Issue 1, pp 83 – 83

Correction to: T cell leukemia control via Ras-Raf pathway inhibition with peptides

Issues

Special Issues

Authors and Affiliations

Marin GH ^*

Rebollo A ^**

Bruzzoni-Giovanelli H ^***

Schinella G ^*

Piazzon I ^****

Duarte A ^****

Errecalde J ^*

* *National University of La Plata - Pharmacology Department-CONICET

** **CIMI, Inserm/UPMC/CNRS- Université Pierre et Marie Curie, Paris 6, France; Centre d’Immunologie et des Maladies Infectieuses

*** ***Université Paris 7- Hôpital Saint Louis, Pharmacology - Centre d’Investigations Cliniques

**** ****National Academy of Medicine, Argentina, Experimental Immunology Laboratory

Correspondence to:Gustavo H. Marin, MD, PhD, National University of Medicine La Plata, CONICET, Argentina Research Group Sorbonne Paris Cite - CIN 60 y 120, Code 1900, La Plata, Argentina, Mobile phone: +5492215030058, E-mail: gmarin2009@gmail.com

Abstract

In the original publication, the authors’ names and their affiliations have been incorrectly typeset. The original article is now corrected.

Keywords

N/A

Preview

JMedLife-11-083

Download PDF

About this article

PMC ID: 5909951
PubMed ID: 29697701
DOI:

Article Publishing Date (print): Jan-Mar 2018
Available Online:

Journal information

ISSN Printing: 1844-122X
ISSN Online: 1844-3117
Journal Title: Journal of Medicine and Life

Copyright License: Open Access

This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use and redistribution provided that the original author and source are credited.